Table 2.
Post-operative complication | Tooth type not specified | Third molar teeth | ||
---|---|---|---|---|
Alveolar osteitis | 0.78%−39.12% [27, 51, 58, 59] | 0.19%–12.7% [27, 54] | ||
Maxillary = 1.21% [59] | Mandibular = 2.69% [59] | Maxillary = 0.38% [48] | Mandibular = 2.7%–4.2% [47, 50, 63] | |
Osteomyelitis | 0.7% [27] | 0.32%−0.37% [27, 47] | ||
Abscess | 0.11% [10] | 0.32%–1.25% [47, 48] | ||
Facial cellulitis | No reports found | 0.08% [64] | ||
Pain | 0.86%−6.76% [10, 27, 58] | 0.3%–1.6% [27, 50, 52] | ||
Inferior alveolar nerve damage | 0.06% [27] | 0.23%–8.4% [47, 52, 54, 63] | ||
Lingual nerve damage | 0.08% [27] | 0.2%−5.7% [47, 49, 50, 54] | ||
Mental nerve damage | No reports found | No reports found | ||
Haemorrhage | 0.55%−13.51% [27, 58] | 0.6%–0.7% [27, 52] | ||
Maxillary = 0.064% [48] | Mandibular = 0.3%–0.4% [47, 50] | |||
Haematoma | No reports found | 0.08% [47] | ||
Trismus | 14.85% [58] | 0.3%−0.41% [51, 53] | ||
Swelling/oedema | 6.75% [58] | 0.06% [52] | ||
Osteonecrosis of the jaw ∗ | 1.9%−3.44% [55, 57] | No reports found | ||
Osteoradionecrosis ∗∗ | 8.5%−19.8% [56, 60] | 28.6% [62] | ||
Maxillary = 2.2%−9.1% [56, 60, 61] | Mandibular = 9.6%–17.6% [56, 60, 61] | |||
Oral–antral communication | 0.94% [27] | 2.4% [48] |
∗Of patients on oral or intravenous bisphosphonates. ∗∗Of patients with a history of head and neck radiotherapy.